Michael Sierra

About

R&D executive with deep expertise in inflammation- and immunology-driven diseases across metabolic and dermatologic indications, with a track record of advancing novel mechanisms into clinical-stage assets. Proven ability to identify, prioritize, and decisively de-risk drug discovery programs, progressing assets to Phase I/II through rigorous scientific and strategic leadership.